HDAC Inhibitors recapitulate Human Disease-Associated Microglia Signatures in vitro
Haage, V. C.; Tuddenham, J. F.; Bautista, A.; White, C. C.; Garcia, F.; Patel, R.; Comandante-Lou, N.; Marshe, V.; Soni, R. K.; Sims, P. A.; Menon, V.; Sproul, A. A.; De Jager, P. L.
Show abstract
Disease-associated microglia (DAM), initially described in mouse models of neurodegenerative diseases, have been classified into two related states; starting from a TREM2-independent DAM1 state to a TREM2 dependent state termed DAM2, with each state being characterized by the expression of specific marker genes1. Recently, single-cell (sc)RNA-Seq studies have reported the existence of DAMs in humans2-6; however, whether DAMs play beneficial or detrimental roles in the context of neurodegeneration is still under debate7,8. Here, we present a pharmacological approach to mimic human DAM in vitro by exposing different human microglia models to selected histone deacetylase (HDAC) inhibitors. We also provide an initial functional characterization of our model system, showing a specific increase of amyloid beta phagocytosis along with a reduction of MCP-1 secretion. Additionally, we report an increase in MITF expression, a transcription factor previously described to drive expression towards the DAM phenotype. We further identify CADM1, LIPA and SCIN as DAM- marker genes shared across various proposed DAM signatures and in our model systems. Overall, our strategy for targeted microglial polarization bears great potential to further explore human DAM function and biology.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- SARS-CoV-2 promotes microglial synapse elimination in human brain organoids 95%
- Loss of function of the mitochondrial peptidase PITRM1 induces proteotoxic stress and Alzheimer's disease-like pathology in human cerebral organoids 94%
- Alzheimer's Disease Patient Brain Extracts Induce Multiple Pathologies in Vascularized Neuroimmune Organoids for Disease Modeling and Drug Discovery 93%
Similar papers in this journal
- Metabolic reprogramming and altered ATP content impair neuroprotective functions of microglia in β-glucocerebrosidase deficiency models 96%
- High throughput identification of genetic regulators of microglial inflammatory processes in Alzheimer's disease 96%
- IRF3 regulates neuroinflammatory responses and the expression of genes associated with Alzheimer's disease. 95%
Similar papers in this journal
- Transcriptional characterization of iPSC-derived microglia as a model for therapeutic development in neurodegeneration 96%
- Pharmacological GCase Activity Enhancement Inhibits Tau Accumulation 95%
- MHCII reduction is insufficient to protect mice from alpha-synuclein-induced degeneration and the Parkinson's HLA locus exhibits epigenetic regulation 93%
Similar papers in this journal
- Triglyceride metabolism controls inflammation and APOE4-associated disease states in microglia 96%
- Jedi-1/MEGF12-mediated phagocytosis controls the pro-neurogenic properties of microglia in the ventricular-subventricular zone 94%
- ciRS-7 and miR7 regulate ischemia induced neuronal death via glutamatergic signaling 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.